News & Events

Aug 21 ’09: Use of Influenza A (H1N1) 2009 Monovalent Vaccine – Recoomendations of the ACIP

This report provides recommendations by CDC’s Advisory Committee on Immunization Practices (ACIP) regarding the use of vaccine against infection with novel influenza A (H1N1) virus. Licensed vaccine is expected to be available by mid-October 2009. Highlights of these recommendations include 1) the identification of five general population target groups for initial focus of vaccination efforts (pregnant women, persons who live with or provide care for infants aged <6 months, health-care and emergency medical services personnel, children and young adults aged 6 months–24 years, and persons aged 25–64 years who have medical conditions that put them at higher risk for influenza-related complications), 2) establishment of a priority for a subset of persons within the initial target groups in the event that initial vaccine availability is unable to meet demand, and 3) guidance on use of vaccine in other adult population groups as vaccine
availability increases.

Download PDF